Back
Sarepta Therapeutics Stock Predictions
Sponsored
SRPT
Sponsored
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
38
SRPT
Sarepta Therapeutics
Last Price:
128.96
Seasonality Move:
11.13%
7 Day Trial
ALL ACCESS PASS
$
7
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.Sarepta Therapeutics Stock Forecast
- Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 24.8% based on the past 27 years of stock performance.
- Sarepta Therapeutics has risen higher in 15 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Sarepta Therapeutics Stock Undervalued?
The current Sarepta Therapeutics [SRPT] share price is $130.19. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal. - SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Sarepta Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 24.8% based on the past 27 years of stock performance.
Sarepta Therapeutics Stock Rating
Sell
38
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics overpriced?
- Sarepta Therapeutics has risen higher in 15 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Sarepta Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com
52-Week Data
52-Week High:
173.25
52-Week Low:
55.25
Prediction Charts
Market Cap:
12.42B
Price in USD:
130.19
Volume:
344.28K
Beta:
1.06
Technical Analysis
SMA50:
128.74
SMA100:
135.10
SMA200:
130.35
52-Wk Change:
21.87%
Stock Predictions
-
Is Sarepta Therapeutics stock public?
Yes, Sarepta Therapeutics is a publicly traded company. -
What is the Sarepta Therapeutics stock quote today?
The Sarepta Therapeutics stock price is 130.19 USD today. -
How to buy Sarepta Therapeutics stock online?
You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-9 | 119.64 | 117.94 | 119.64 | 116.17 |
Oct-10 | 119.69 | 122.45 | 124.66 | 118.43 |
Oct-11 | 122.41 | 124.51 | 125.96 | 122.17 |
Oct-14 | 124.42 | 124.37 | 124.94 | 122.74 |
Oct-15 | 124.37 | 123.72 | 124.98 | 123.22 |
Oct-16 | 123.66 | 125.92 | 126.35 | 123.66 |
Oct-18 | 124.98 | 127.08 | 130.04 | 124.26 |
Oct-21 | 127.73 | 127.28 | 129.24 | 126.58 |
Oct-22 | 126.26 | 128.42 | 128.54 | 126.21 |
Oct-23 | 131.00 | 129.88 | 131.00 | 126.78 |
Oct-24 | 129.90 | 132.02 | 132.88 | 129.53 |
Oct-25 | 132.10 | 131.14 | 133.36 | 130.93 |
Oct-28 | 131.37 | 130.26 | 132.80 | 129.26 |
Oct-29 | 130.07 | 130.19 | 131.17 | 129.26 |
Sarepta Therapeutics Earnings
Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sarepta Therapeutics Forecast Revenue Growth
Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $2.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $8.77 per share.
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.